InvestHub

Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics, Inc., a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused on creating novel therapeutic agents for various immune-inflammatory conditions.

Descriptive
Exchange
Industry
Country
Active:none
CompanyRating
Loading data…

Saved screens and full data - with a subscription

Subscribe to save filters and unlock all columns and ratings.

Subscribe - €24.90/mo